Incidence and Prevalence of Primary Sclerosing Cholangitis: A Meta-analysis of Population-based Studies
Jared Cooper, Ante Markovinovic, Stephanie Coward, Michelle Herauf, Abdel-Aziz Shaheen, Mark Swain, Remo Panaccione, Christopher Ma, Cathy Lu, Kerri Novak, Karen I Kroeker, Siew C Ng, Gilaad G Kaplan- Gastroenterology
- Immunology and Allergy
Abstract
Background
Primary sclerosing cholangitis is a chronic liver disease associated with significant morbidity, mortality, and healthcare utilization. We conducted a systematic review and meta-analysis of population-based studies of the incidence and prevalence of primary sclerosing cholangitis.
Methods
Medline and Embase were systematically searched to identify population-based studies of a defined geographic area and reported the incidence or prevalence of primary sclerosing cholangitis in the general population. Meta-analyses, using random-effects, were performed to calculate overall and country-specific incidence (per 100 000 persons/year) and prevalence rates (per 100 000 persons) with 95% confidence intervals.
Results
The 14 studies on incidence and the 12 for prevalence originated from North America, Asia, Europe, and Oceania. Incidence and prevalence rates of primary sclerosing cholangitis were 0.87 (95% confidence interval, 0.59-1.29) and 13.53 (95% confidence interval, 10.20-17.94) per 100 000 persons, respectively.
Conclusions
Both the prevalence and incidence of primary sclerosing cholangitis is low in the general population. Future studies on the incidence and prevalence of primary sclerosing cholangitis in the general population should be directed at Asia, Africa, and Latin America to allow for a more robust assessment of the global epidemiology of primary sclerosing cholangitis.